1
Yan Y#, Shang L#, Xu J, Gu X, Fan G, Wang Y, Cao B*. The prevalence and outcomes of viremia in patients with acute respiratory viral infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2025 Jan 28:S1198-743X(25)00035-7. doi: 10.1016/j.cmi.2025.01.027. Epub ahead of print. PMID: 39884502.
2
Yan M#, Shang L#, Wang Y#, Wang C, Cao B*. Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis. Int J Antimicrob Agents. 2025 Jan 4;65(3):107440. doi: 10.1016/j.ijantimicag.2024.107440. Epub ahead of print. PMID: 39761759.
3
Zhuo X#, Lei Z, Pu D, Wu Y, Zhao J*, Cao B*. Hypervirulent Klebsiella pneumoniae have better clinical outcomes than classical Klebsiella pneumoniae for lower respiratory tract infection patients. BMC Microbiol. 2025 Jan 22;25(1):40. doi: 10.1186/s12866-024-03726-2. PMID: 39844054; PMCID: PMC11753108.
4
Wang Y#, Wang H#, Zhang Y#, Ma A#, Liu D#, Li X, Yang G, Deng M, Wang S, Liu Y, Liu C, Ge F, Wang S, Yu Y, Feng G, Xiao Z, Li X, Sun Y, Chen X, Cao Z, Ding Y, Wu X, Wei J, Cao B*. Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03419-3.
